Association between growth differentiation factor-15 and cardiovascular risk in patients with type 2 diabetes mellitus
Background and aim As most diabetic patients have high risk of cardiovascular hazards, the aim was to assess an indicator biomarker that can help us to estimate these hazards in patients with type 2 diabetes (T2D). Patients and methods A total of 80 participants were examined for T2D and divided int...
Main Authors: | Fatma E.-Z.M Abu-Bakr, Mona M Abdel-Meguid, Eglal M Qenawy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Al-Azhar Assiut Medical Journal |
Subjects: | |
Online Access: | http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=4;spage=380;epage=384;aulast=Abu-Bakr |
Similar Items
-
Growth differentiation factor-15 (GDF-15) for cardiovascular risk assessment
by: Wiesław Piechota, et al.
Published: (2018-03-01) -
Predictive value of growth differentiation factor-15 in patients with myocardial infarction
by: A. A. Sabirzyanova, et al.
Published: (2021-03-01) -
Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease
by: Man Li, et al.
Published: (2020-08-01) -
Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome
by: Vasanthi Murugaiyan, et al.
Published: (2020-01-01) -
PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)